Merck & Co., Inc. is 9.2x more valuable than BeOne Medicines AG by market capitalization ($294.13 B vs $32.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ONC | MRK |
|---|---|---|
| Market cap | $32.14 B | $294.13 B |
| US-listed rank | #444 | #44 |
| Revenue (latest FY) | $5.34B | $65.01B |
| Net income (latest FY) | $286.93M | $18.25B |
| Net margin | 5.4% | 28.1% |
| P/E (trailing FY) | 112.0 | 16.1 |
| SEC filings | 1,167 | 996 |
Merck & Co., Inc. is 9.2x more valuable than BeOne Medicines AG by market capitalization ($294.13 B vs $32.14 B).
In their latest fiscal years, BeOne Medicines AG reported $5.34B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: BeOne Medicines AG and Merck & Co., Inc., or browse the full rankings.